Antidepressant effects of ketamine in depressed patients

Boyer, 1998, Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study, J Mol Neurosci, 10, 219, 10.1007/BF02761776

Crane, 1959, Cycloserine as an antidepressant agent, Am J Psychiatry, 115, 1025, 10.1176/ajp.115.11.1025

Crane, 1961, The psychotropic effects of Cycloserine, Compr Psychiatry, 2, 51, 10.1016/S0010-440X(61)80007-2

Domino, 1965, Pharmacologic effects of CI-581, a new dissociative anesthetic, in man, Clin Pharmacol Ther, 6, 279, 10.1002/cpt196563279

Eide, 1997, Ketamine, Pain, 72, 289, 10.1097/00006396-199708000-00042

Elliot, 1995, N-Methyl-D-Aspartate (NMDA) receptors, μ and κ opioid tolerance, and perspective on new analgesic drug development, Neuropsychopharmacology, 13, 347, 10.1016/0893-133X(95)00083-P

First, 1997

Krystal, 1994, Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses, Arch Gen Psychiatry, 51, 199, 10.1001/archpsyc.1994.03950030035004

Layer, 1995, Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715), Pharmacol Biochem Behav, 52, 621, 10.1016/0091-3057(95)00155-P

Lindefors, 1997, Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex, Brain Res, 759, 205, 10.1016/S0006-8993(97)00255-2

Malhotra, 1996, Loading dose imipramine—new approach to pharmacotherapy of melancholic depression, J Psychiatric Res, 30, 51, 10.1016/0022-3956(95)00042-9

Meloni, 1993, Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats, Pharmacol Biochem Behav, 46, 423, 10.1016/0091-3057(93)90374-3

Mjellem, 1993, Reduction of NMDA-induced behavior after acute and chronic administration of desipramine in mice, Neuropharmacology, 32, 591, 10.1016/0028-3908(93)90055-8

Moryl, 1993, Potential antidepressive properties of amantadine, memantine and bifemelane, Pharmacol Toxicol, 72, 394, 10.1111/j.1600-0773.1993.tb01351.x

Panconi, 1993, MK-801 and enantiomers, Pharmacol, Biochem Behav, 46, 15, 10.1016/0091-3057(93)90310-P

Papp, 1994, Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression, Eur J Pharmacol, 263, 1, 10.1016/0014-2999(94)90516-9

Papp, 1996, Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and D-cycloserine in an animal model of depression, Eur J Pharmacol, 316, 145, 10.1016/S0014-2999(96)00675-9

Paul, 1994, Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments, J Pharmacol Exp Ther, 269, 95

Pollock, 1989, Acute antidepressant effect following pulse loading with intravenous and oral clomipramine, Arch Gen Psychiatry, 46, 29, 10.1001/archpsyc.1989.01810010031005

Przegalinski, 1997, Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist, Neuropharmacology, 36, 31, 10.1016/S0028-3908(96)00157-8

Sallee, 1997, Pulse intravenous clomipramine for depressed adolescents, Am J Psychiatry, 154, 668, 10.1176/ajp.154.5.668

Skolnick, 1996, Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment, Pharmacopsychiatry, 29, 23, 10.1055/s-2007-979537

Trullas, 1990, Functional antagonists at the NMDA receptor complex exhibit antidepressant actions, Eur J Pharmacol, 185, 1, 10.1016/0014-2999(90)90204-J

Vale, 1971, Amantadine in depression, Lancet, 2, 437, 10.1016/S0140-6736(71)90153-X

Wong, 1996, Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats, Eur J Pharmacol, 297, 27, 10.1016/0014-2999(95)00728-8